On the January 17th 2014 the Medical University of Warsaw will host a conference focused on ways of applying for funding for biomedical research projects in the framework of the Innovative Medicines Initiative (IMI) . The conference combined with practical workshops is addressed to researchers, small and medium-sized businesses , nonprofit organizations , government agencies and other institutions supporting, leading or interested in participating in research projects .
The Innovative Medicines Initiative (IMI) is Europe’s largest public-private initiative aiming to speed up the development of better and safer medicines for patients. IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe. IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.
Till now IMI invested about 1.5 billion euros in research projects carried out by public and private partners . The next round of calls for proposals covering 8 projects will be published in December 2013 . The budget for grants to potential beneficiaries is approximately 170 million Euros.
The organizers of the conference are : Medical University of Warsaw, the project BASTION , the Innovative Medicines Initiative Joint Undertaking and the European Federation of Pharmaceutical Industries and Associations (EFPIA), together with the Association of Employers of Innovative Pharmaceutical Companies INFARMA.